← Back

Wire · opportunities

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical ...

Published

1 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at businesswire.com →

◆ Verified

Fusion42 · 1 October 2026 · Fusion42 review

Edwards Lifesciences received FDA approval for the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease, allowing valve expansion as the child grows and potentially reducing repeat open-heart surgeries.

This Wire brief sits within Fusion42's coverage of Medtech, and 15 sources have reported it between 1 Oct 2026 and 13 Oct 2026.

◆ ◆ The Wire takeaway

You can now target a paediatric heart surgery market with fewer complications and less repeat surgery. This approval opens a path for products designed specifically for paediatric growth, shifting competitive priorities in surgical valve development.

◆ Coverage

15 sources · first reported 1 Oct 2026 · latest 13 Oct 2026

◆ Related on Wire

◆ Topics

MedtechFDA-approvalpediatric-medical-deviceheart-diseasesurgical-valvemedtech-innovation